Sept 19 (Reuters) - Perrigo Co said it received final approval from U.S. health regulators for Ciclopirox topical solution, a generic version of Sanofi-Aventis' Penlac nail-fungus treatment. The ...

SAN FRANCISCO (MarketWatch) -- Perrigo Co. after Monday's closing bell said the Food and Drug Administration has granted tentative approval for its ciclopirox topical solution, 8%. The solution is a ...

Co announces that it has received final approval from the FDA to manufacture and market Ciclopirox Topical Solution, 8%. Shipments will begin immediately. The product has been determined to be ...

Onychomycosis is the most common disease of nails, with a prevalence of up to 14% in Western adult populations. Whereas tinea unguium refers strictly to dermatophyte fungal infection of the nail plate ...